In terms of angiogenesis, EGCG has been demonstrated to inhibit tumor-secreted factors such as vascular endothelial growth factor (VEGF) in endometrial [56], lung [57], gastric [58], and breast cancer [57,59]. This evidence concerns the gene VEGFA and breast carcinoma.